Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waismann Method Medical Group is a private U.S. healthcare services organization focused on medically supervised treatment for opioid dependence and withdrawal. The company is best known for the Waismann Method, a hospital-based rapid opioid detoxification approach performed in Southern California with individualized medical evaluation, sedation-assisted detox protocols, and follow-on recovery support. Its business appears to center on clinical treatment services and patient education rather than drug development. The organization markets itself as a specialized opioid detox and withdrawal-management provider founded in 1998 and serving patients through a single Southern California center. It is not a biotech or pharma developer and does not appear to maintain a conventional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waismann Method Medical Group.